Health: Antidepressant for COVID-19 reduces hospitalization...
October 29, 2021
The anti-depressant drug fluvoxamine is being looked at by researchers as a possible treatment for COVID-19. A recently released study showed the drug showed a reduced risk of hospitalization and death among COVID patients. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed for a Health.com story on the study results.